Effects of endogenous testosterone and estradiol on sexual behavior in normal young men
Loading...
Date
Authors
Bremner, William J.
Rivier, Jean E.
Bagatell, Carrie J.
Heiman, Julia R.
Journal Title
Journal ISSN
Volume Title
Publisher
Endocrine Society
Abstract
The importance of androgens in establishing and maintaining sexual
function in males of most species is well recognized. Estrogens also
stimulate male sexual function in some species. In men, most studies of
androgen effects on behavior have used hypogonadal men as an experimental
model; much less is known about the role of endogenous testosterone (T) or
estradiol (E2) in the regulation of behavior in healthy, eugonadal men. In
a randomized, double-blind study, we used a GnRH antagonist, Nal-Glu,
without T replacement, to induce acute, profound, reversible gonadal
steroid deficiency in 9 normal men for 6 weeks (Nal-Glu alone). We also
studied the effects of partial androgen replacement by administering
Nal-Glu together with T enanthate, 50 mg im weekly, to 10 other men. A
third group of 10 men received Nal-Glu plus T, 100 mg im weekly. We
studied the role of endogenous E2 by administering Nal-Glu plus T, 100 mg
im weekly, plus an aromatase inhibitor, testolactone (Teslac), 250 mg po
qid, to 10 additional men (Nal - Glu + T + Teslac). Nine men received
placebo injections and tablets. All subjects completed a behavioral
questionnaire during the pretreatment period, at weeks 2, 4, and 6 of
treatment, and at 3 weeks posttreatment. Men who received Nal-Glu alone
became profoundly hypogonadal within 1 week after treatment began. Serum T
levels did not change significantly in the controls and in the men who
received full T replacement but decreased to approximately half the
baseline level in men who received partial T replacement. E2 levels
decreased profoundly in men who received Nal-Glu alone or Nal - Glu + T +
Teslac and to a lesser degree in men who received partial T replacement.
In men who received Nal-Glu alone, there were clinically and statistically
significant decreases in the frequency of sexual desire, sexual fantasies,
and intercourse at 4-6 weeks. These men also showed a strong trend (P =
0.55) towards decreased spontaneous erections after 4 and 6 weeks of
treatment. A significant decrease in the frequency of masturbation was
evident after 6 weeks. All measures returned to normal by posttreatment
week 3. There was a trend toward increased aggression in the hypogonadal
men, but this did not reach statistical significance. No changes in
satisfaction or happiness with their partners were observed.(ABSTRACT
TRUNCATED AT 400 WORDS)
Description
Citation
J Clin Endocrinol Metab. 1994 Mar;78(3):711-6
